Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-26 @ 12:17 PM
Ignite Modification Date:
2025-12-26 @ 12:17 PM
NCT ID:
NCT03173300
Eligibility Criteria:
Inclusion Criteria:
* Informed consent/assent by the patient and/or their legally authorized representative
* Confirmed diagnosis of PMM2-CDG, based on enzymatic or molecular tests
* Willing and able to adhere to study requirements described in the protocol and consent/assent documents
Exclusion Criteria:
* Known or suspected differential diagnosis of any other known CDG (not PMM2-CDG)
* Currently using investigational drug
* Blood loss of ≥ 250 mL or donated blood within 56 days, or donated plasma within 7 days before study screening
Healthy Volunteers:
False
Sex:
ALL
Study:
NCT03173300
Study Brief:
Protocol Section:
NCT03173300